Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target populationChristopher Blaum, Christoph Waldeyer, Thiess Lorenz et al.|European Journal of Preventive Cardiology|2019Cited by 57
Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort StudyChristoph Waldeyer, Renate B. Schnabel, Moritz Seiffert et al.|Clinical Therapeutics|2017Cited by 18